Clarissa M Koch

4PUBLICATIONS
26CO-AUTHORS
Innate immunityNon-genetically modified uses of biotechnologySouth-East Asian languages (excl. Indonesian)Infant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Feb 04, 2026
Phase 1 and preclinical studies reveal safety, pharmacokinetics, and efficacy of intranasal delivery of the influenza antibody CR9114.

Anna L Beukenhorst, Robin Rogiers, Keira L Rice

|Feb 04, 2023
SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.

Anna L Beukenhorst, Clarissa M Koch, Christoforos Hadjichrysanthou

|Nov 03, 2021
Age-related Differences in the Nasal Mucosal Immune Response to SARS-CoV-2.

Clarissa M Koch, Andrew D Prigge, Kishore R Anekalla

|Feb 16, 2018
Inflammatory Monocytes Drive Influenza A Virus-Mediated Lung Injury in Juvenile Mice.

Bria M Coates, Kelly L Staricha, Clarissa M Koch

Pageof 1